{"authors": [["Huang", "Chih-Yang", "CY", "Translation Research Core, China Medical University Hospital, China Medical University, Taichung, Taiwan."], ["Kuo", "Chia-Hua", "CH", "Department of Sports Sciences, University of Taipei, Taipei, Taiwan."], ["Pai", "Pei-Ying", "PY", "Division of Cardiology, China Medical University Hospital, Taichung, Taiwan."], ["Ho", "Tsung-Jung", "TJ", "School of Chinese Medicine, China Medical University, Taichung, Taiwan."], ["Lin", "Yueh-Min", "YM", "Department of pathology, Changhua Christian Hospital, Changhua, Taiwan."], ["Chen", "Ray-Jade", "RJ", "Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan."], ["Tsai", "Fuu-Jen", "FJ", "School of Chinese Medicine, China Medical University, Taichung, Taiwan."], ["Vijaya Padma", "V", "V", "Department of Biotechnology, Bharathiar University, Coimbatore 641046, India."], ["Kuo", "Wei-Wen", "WW", "Department of Biological Science and Technology, China Medical University, Taichung, Taiwan."], ["Huang", "Chih-Yang", "CY", "School of Chinese Medicine, China Medical University, Taichung, Taiwan."]], "text": "In association with the published article \"Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy\" (Huang et al., 2017) [1], this data article contains information about deSUMOylation of HSF2 on lysine 82 on angiotensin II (ANG II) -induced cardiac hypertrophy, which is mediated by MEL18. Isolated adult human whole heart tissue showed MEL18-mediated HSF2-IGF-IIR pathway is upregulated in hypertension human heart, compared to health human heart.", "id": "29270451", "date": "2017-11-20", "title": "Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure.", "doi": "10.1016/j.dib.2017.11.040", "journal": ["Data in brief", "Data Brief"]}